443 related articles for article (PubMed ID: 16936272)
1. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.
Kawai T; Matsuyama T; Hosokawa Y; Makihira S; Seki M; Karimbux NY; Goncalves RB; Valverde P; Dibart S; Li YP; Miranda LA; Ernst CW; Izumi Y; Taubman MA
Am J Pathol; 2006 Sep; 169(3):987-98. PubMed ID: 16936272
[TBL] [Abstract][Full Text] [Related]
2. Immune response: the key to bone resorption in periodontal disease.
Taubman MA; Valverde P; Han X; Kawai T
J Periodontol; 2005 Nov; 76(11 Suppl):2033-41. PubMed ID: 16277573
[TBL] [Abstract][Full Text] [Related]
3. Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.
Kanzaki H; Makihira S; Suzuki M; Ishii T; Movila A; Hirschfeld J; Mawardi H; Lin X; Han X; Taubman MA; Kawai T
J Immunol; 2016 Nov; 197(10):3871-3883. PubMed ID: 27815441
[TBL] [Abstract][Full Text] [Related]
4. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.
Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I
Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
Valverde P; Kawai T; Taubman MA
J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
[TBL] [Abstract][Full Text] [Related]
6. Bacterial-responsive B lymphocytes induce periodontal bone resorption.
Han X; Kawai T; Eastcott JW; Taubman MA
J Immunol; 2006 Jan; 176(1):625-31. PubMed ID: 16365458
[TBL] [Abstract][Full Text] [Related]
7. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts.
Hormdee D; Nagasawa T; Kiji M; Yashiro R; Kobayashi H; Koshy G; Noguchi K; Nitta H; Ishikawa I
Clin Exp Immunol; 2005 Dec; 142(3):490-7. PubMed ID: 16297161
[TBL] [Abstract][Full Text] [Related]
9. Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease.
Ernst CW; Lee JE; Nakanishi T; Karimbux NY; Rezende TM; Stashenko P; Seki M; Taubman MA; Kawai T
Clin Exp Immunol; 2007 May; 148(2):271-80. PubMed ID: 17355249
[TBL] [Abstract][Full Text] [Related]
10. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
11. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.
Teng YT; Nguyen H; Gao X; Kong YY; Gorczynski RM; Singh B; Ellen RP; Penninger JM
J Clin Invest; 2000 Sep; 106(6):R59-67. PubMed ID: 10995794
[TBL] [Abstract][Full Text] [Related]
12. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells.
Choi Y; Woo KM; Ko SH; Lee YJ; Park SJ; Kim HM; Kwon BS
Eur J Immunol; 2001 Jul; 31(7):2179-88. PubMed ID: 11449372
[TBL] [Abstract][Full Text] [Related]
13. The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.
Belibasakis GN; Johansson A; Wang Y; Chen C; Kalfas S; Lerner UH
Infect Immun; 2005 Jan; 73(1):342-51. PubMed ID: 15618171
[TBL] [Abstract][Full Text] [Related]
14. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
Mogi M; Otogoto J; Ota N; Togari A
J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
17. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue.
Ogasawara T; Yoshimine Y; Kiyoshima T; Kobayashi I; Matsuo K; Akamine A; Sakai H
J Periodontal Res; 2004 Feb; 39(1):42-9. PubMed ID: 14687227
[TBL] [Abstract][Full Text] [Related]
18. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
Takayanagi H; Ogasawara K; Hida S; Chiba T; Murata S; Sato K; Takaoka A; Yokochi T; Oda H; Tanaka K; Nakamura K; Taniguchi T
Nature; 2000 Nov; 408(6812):600-5. PubMed ID: 11117749
[TBL] [Abstract][Full Text] [Related]
19. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells.
Toraldo G; Roggia C; Qian WP; Pacifici R; Weitzmann MN
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):125-30. PubMed ID: 12490655
[TBL] [Abstract][Full Text] [Related]
20. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.
O' Gradaigh D; Ireland D; Bord S; Compston JE
Ann Rheum Dis; 2004 Apr; 63(4):354-9. PubMed ID: 15020327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
